Intensive versus routine blood pressure control in patients with type 2 diabetes: a meta-analysis and trial sequential analysis.

Optimal blood pressure (BP) targets for type 2 diabetes remain controversial. Although intensive BP control reduces cardiovascular risk in the general population, its net benefit in diabetes is uncertain. We conducted a systematic review and meta-analysis of randomized controlled trials comparing intensive BP control (target < 130/80 mmHg or achieved systolic <130 mmHg) with routine control in adults with type 2 diabetes. Databases (PubMed, Embase, Cochrane CENTRAL) were searched through November 2024; two reviewers independently extracted data and assessed bias. Random-effects meta-analysis estimated pooled relative risks (RRs) with 95% confidence intervals (CIs), and trial sequential analysis (TSA) assessed robustness. Eleven trials comprising 24,308 participants met inclusion criteria. Intensive BP control reduced stroke (RR: 0.64; 95% CI: 0.51-0.81) and major cardiovascular events (RR: 0.86; 95% CI: 0.72-1.03) with no significant differences in mortality or heart-failure hospitalization. TSA confirmed firm evidence for stroke reduction, mortality and heart failure results remained inconclusive.

• Publication year

  2026

• Venue

  Journal of Hypertension

• Publication date

  2026-02-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/HJH.0000000000004267PMID 41661191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of intensive versus standard blood pressure control on cardiovascular outcomes in adult patients with hypertension: a systematic review and meta-analysis

  2025cited by this paper
• Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.

  2024cited by this paper
• The winner's curse: why large effect sizes in discovery trials always get smaller and often disappear completely

  2023cited by this paper
• Effect of more versus less intensive blood pressure control on cardiovascular, renal and mortality outcomes in people with type 2 diabetes: A systematic review and meta-analysis.

  2023cited by this paper
• Intensive versus standard blood pressure control in older persons with or without diabetes: a systematic review and meta-analysis of randomised controlled trials

  2023cited by this paper
• Blood Pressure Target in Type 2 Diabetes Mellitus

  2022cited by this paper
• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

  2021cited by this paper
• RoB 2: a revised tool for assessing risk of bias in randomised trials

  2019cited by this paper
• Intensive multifactorial intervention improved renal impairment in short-duration type 2 diabetes: A randomized, controlled, 7-year follow-up trial.

  2019cited by this paper
• Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis

  2019cited by this paper
• Hypertension in patients with type 2 diabetes mellitus: Targets and management.

  2018cited by this paper
• Intensive versus standard multifactorial cardiovascular risk factor control in screen‐detected type 2 diabetes: 5‐year and longer‐term modelled outcomes of the ADDITION‐Leicester study

  2018cited by this paper
• Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

  2018cited by this paper
• From the Editors’ Desk: Bias in Systematic Reviews—Let the Reader Beware

  2018cited by this paper
• Blood pressure control in type 2 diabetic patients

  2017cited by this paper
• Trial Sequential Analysis in systematic reviews with meta-analysis

  2017cited by this paper
• Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.

  2017cited by this paper
• Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

  2016cited by this paper
• Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

  2016cited by this paper
• A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

  2016cited by this paper
• Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.

  2015cited by this paper
• Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis.

  2012cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.

  2006cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

  2000cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper

• No citing papers are available for this paper.